Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

Indicative Announcement on Unlocking of the 3rd Sales Restriction Lifting Period under the 2022 Restricted Stock Incentive Plan and Unlocking and Listing of the 2nd Sales Restriction Lifting Period under the 2024 Restricted Stock Incentive Plan

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Unlocking of the 3rd Sales Restriction Lifting Period under the 2022 Restricted Stock Incentive Plan and Unlocking and Listing of the 2nd Sales Restriction Lifting Period under the 2024 Restricted Stock Incentive Plan

The total number of shares to be listed and circulated this time is 3,298,680; the listing and circulation date is June 17, 2026.



The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis